Chesapeake Asset Management’s Halozyme HALO Stock Holding History

Chesapeake Asset Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-130	Closed	-$8.75K	–	355
2025 Q4	$8.75K	Buy	+130	New	+$8.74K	0.01%	263

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chesapeake Asset Management's HALO Position: Q1 2026 in Review

Chesapeake Asset Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 130 shares — an estimated $8.75K sold.

Chesapeake Asset Management first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $8.75K in Q4 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Chesapeake Asset Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Chesapeake Asset Management sold 130 Halozyme shares in Q1 2026, an estimated $8.75K.
Chesapeake Asset Management first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
Chesapeake Asset Management's Halozyme position peaked at $8.75K in Q4 2025.
636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.